EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Tzogani, Kyriaki, Hennik, Paula Van, Walsh, Ita, De Graeff, Pieter, Folin, Annika, Sjöberg, Jan, Salmonson, Tomas, Bergh, Jonas, Laane, Edward, Ludwig, Heinz, Gisselbrecht, Christian, Pignatti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058342/
https://www.ncbi.nlm.nih.gov/pubmed/30037941
http://dx.doi.org/10.1634/theoncologist.2017-0301erratum

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058342/
https://www.ncbi.nlm.nih.gov/pubmed/30037941
http://dx.doi.org/10.1634/theoncologist.2017-0301erratum

Ejemplares similares